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Executive Summary 
 
This study examines the effects of pre-freezing on the RF ablation of lung cancer, a 
widespread disease in the United States.  While current treatments utilize cryosurgery or RF 
ablation to destroy lung tumors, neither method ensures the tumor destruction.  Sun et al. (2008) 
describes an alternative treatment combining both cryosurgery and RF heating techniques, 
consisting of 10 minutes of pre-freezing with a -150°C probe followed by 30 minutes of RF 
heating (1).  Pre-freezing acts to lower the inactivation energy of the tissue, resulting in an 
increased radius of tumor death for the same duration of resistive heating.  The study aims to 
examine the effects of pre-freezing on RF ablation surgery of a lung tumor, verify the findings of 
Sun et al. using COMSOL, and examine the sensitivity of the freeze-thaw procedure to tumor 
and tissue material properties. 
COMSOL Multiphysics was used to model the freeze-thaw procedure for a lung tumor 
with a 16.7 mm radius, in comparison with simple RF heating.  Pre-freezing was simulated as 
heat transfer by conduction with a constant -150°C temperature probe with a 2.5 mm probe 
radius, and accounted for latent heat in tabulated data for apparent specific heat of the tissue.  RF 
heating was simulated by implementing the voltage equation to account for resistive heat 
generation in the tissue.  Cell radius of tumor death was calculated using an equation for cell 
death due to heating formulated by Sun et al. (2008). 
The COMSOL model was verified by comparing the cell death radius to values reported 
by Sun (2008). The applied voltage was first set to 17.6 V to destroy a tumor radius of 8.7 mm 
with simple RF heating as observed by Sun et al. (2008).   The freeze-thaw procedure was 
implemented for a range of inactivation energy values from 136 to150 kcal/mol. The energy of 
inactivation energy required for a tumor death radius of 12.7 mm was143200 cal/mol, a 0.0485% 
difference from the literature reported of 143,898 cal/mol.  For the tumor we modeled in 
COMSOL, the voltage was adjusted to 20 V to destroy the entire area of tumor and minimize 
damage to normal tissue.  A sensitivity analysis was conducted for thermal conductivity, density, 
and specific heats of the tissue and tumor, and inactivation energy. 
The model demonstrated that ten minutes of pre-freezing can increase the effectiveness of 
RF ablation. This resulted in a larger area of tumor destruction and allows for a lower voltage or 
reduced duration of probe contact.   Furthermore, the material properties of the tumor and 
surrounding tissue had a minimal effect on the radius of tumor death, suggesting variation 
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between patients and tumor composition would have little effect on the effectiveness of the 
freeze-thaw treatment.   
Before the procedure could be used for animal trials or human use, the required voltage 
for the freeze-thaw treatment of various tumor sizes and geometries must be calculated, and the 
model should be run using all biologically probable parameters.  Nonetheless, the freeze-thaw 
procedure combines cryosurgical and RF ablation surgical techniques that have already been 
proven safe and effective for human use.  Therefore, the freeze-thaw procedure may improve the 
outcome of lung cancer cases with minimal cost to develop and comparable patient risk to 
current treatment procedures. 
 
Introduction 
 
Lung cancer is a very prevalent disease in the United States and can be treated using a 
variety of methods including: invasive surgery, chemotherapy, radiation, and localized thermal 
treatment (2).  Thermal treatment methods include both cryosurgery and radiofrequency (RF) 
heating.  Cryosurgery is a localized and minimally invasive method of treatment, but it can cause 
direct cellular injury, vascular injury, and possible immune reactions.   RF heating penetrates 
deep into tissue but can initiate metastasis.  Unfortunately, neither method of treatment 
guarantees complete destruction of the tumor (1).  A novel system developed to treat lung cancer 
has combined both of these treatment methods, using a system designed to freeze and then warm 
the tissue in a series of cycles.  The combination of these two stages causes more damage than 
either alone because the deep tissue heat generation in frozen tissue causes heterogeneity and 
damaging thermal stress.   
Much medical research has been aimed at treating tumor tissue with minimal destruction 
of surrounding normal tissue. To improve tumor shape confirmation, several techniques have 
been tried, including cool tip RF probes and multi-probe arrays (1). In 2004, Cabrera et al. 
submitted a student project that investigated the use of cryosurgery to treat a cancerous 
cylindrical mass in lung tissue (3).  From this project an optimal freezing time was determined 
that would successfully freeze the tumor while minimizing damage to the surrounding normal 
tissue.  In 1982, Gage et al. proposed the method of combining freezing and heating for the first 
time (4). Liu et al. then designed a cryo-probe system with vapor heating, and concluded that 
cooling immediately followed by vapor heating would improve treatment effect due to thermal 
stress. Sun et al. (1) recently used a nude mouse dorsal skin flab chamber tumor model to study 
this type of system.  To provide Nitrogen cooling and RF heating alternatively, they used a metal 
probe with circulating fluid for a freezing effect, and a current running through a wire to generate 
an RF effect. For analysis they used a bio heat transfer model to show temperature changes and 
to predict the therapeutic effect at the cellular and tissue levels. The study demonstrated that 
tumor cells and vessels were completely destroyed after alternate treatment, whereas neither 
cooling nor heating alone achieved same effects.   
The alternative treatment process entails ten minutes of freezing followed by thirty 
minutes of RF heating treatment. In the cryosurgical freezing process, the probe is quickly 
cooled by the flow of liquid nitrogen.  During this ten minute cooling stage a ball of ice is 
formed in the affected tumor tissue and blood perfusion is assumed to be inhibited in all regions 
that reach a temperature below 0°C.  The probe then switches function and enters a thirty minute 
RF heating stage. In this heating stage deep tissue heat generation causes thermal stress and 
heterogeneity in the affected tissue such that it becomes more damaged that normal 
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Design Schematic:  
 
The schematic used to model the destruction of a tumor in healthy lung tissue shows 
boundary conditions for both freezing and heating stages (Figure 1).  The left boundary has been 
set as an axis of symmetry to create a 3D model in COMSOL.  The probe, which does not appear 
in this schematic, is placed along the axis of symmetry on top of the tumor.  The temporal plot of 
the alternative treatment shows the timescale of the procedure (Figure 2). 
 
 
Figure 1: A schematic of the lung tumor and tissue system to be modeled in COMSOL. 
 
 
Figure 2: Temporal plot of the alternative treatment to visually represent the timescale and 
relationship between different parts of the thermal cycling treatment. 
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Establishing the Model in COMSOL 
 
We selected the two dimensional axial symmetry to most accurately model the structures 
we desired and then initiated two different multiphysics systems: transient heat transfer (for 
heating and cooling processes) and conductive media DC (for RF heating).  The value for the 
apparent specific heat (cpa) was included in the governing equation (Appendix A, Equation 1A) 
for cooling to account for the freezing of the material.  The expression for cpa describing the 
changes in cpa during the freezing process is given in Equation 1b. For this step, the heat flux 
along the edges of our model was considered to be negligible.   
The governing equation for heat transfer during RF heating (Appendix A, Equation 2A) 
used the same equation as for freezing, but included a heat generation term.  This generation 
term comes from the heat generated by resistive heating of the radiofrequency heating (RF) 
probe, which is modeled by an equation relating electric field to voltage and position (Appendix 
A, Equation 3A).  For the voltage equation, boundary conditions were set such that the tissue in 
contact with air was insulated, the boundary along the axis of symmetry had axial symmetry, and 
the tissue in contact with the rest of the body was grounded.  For the heating stage, each edge 
was considered to have a no flux boundary condition (Appendix A, Equation 4A). 
Within COMSOL, we input the parameter values in the appropriate locations under 
subdomain settings (Appendix A, Table 1A).  For the heat capacity, we defined a function called 
heat_cap that was based on interpolation between points we entered (Appendix A, Table 2A).  
Under global expressions, we included equations for k_s and cell_survival_heating in order to 
determine the extent of damage caused by variations in procedure based on the equations 
provided in Sun et al. (2008). 
The equation used by Sun et al. to find cell survival rate is given by (Appendix B, 
Equation 1B).  In this equation, n = 100 and F(t) is a function quantifying the amount of 
damaged protein. A calculation of 1 indicates cell survival, 0 indicates cell death. The variable ks 
is the rate of protein denaturization, and is modeled by Equation 2B (Appendix B). The normal 
value for ΔH, given by Sun et al., is 145149 cal/mole, and that after pre-freezing is 143898 
cal/mole. Δs is an extensive state function that accounts for the effect of irreversibility in a 
thermodynamic system. The smallest functional unit in a living system, a cell, can be considered 
as such a system, hence our use of it in this model. The value used here was -374.5 cal K
-1   
mole
-1. 
 
Design Objectives 
 
The first design objective was to accurately model a thermal cycling treatment in 
COMSOL.  This included implementing the governing equations for energy transfer and 
connecting the separate thermal stages in an overall model.  COMSOL was used to create a 
model of the lung tumor and to analyze the effects of applying a thermal cycling probe placed in 
the middle of the lung tumor. The second design objective was to develop a model that would 
minimize cell survival rate in cancerous tissue and maximize the survival rate in the surrounding 
healthy tissue.  The probe’s optimal heating and cooling cycles were determined by using the cell 
death equations provided by Sun et. al. (Appendix B, Equation 1B).       Group 11  5/24 
 
Methods and Results 
 
Mesh Convergence 
 
  Initial examination of our model required a mesh optimization in order to determine the 
minimum mesh size that would achieve convergence.  This optimization was important because 
convergence is necessary in order to yield accurate results but the smaller the mesh, the longer 
the computation time.  Therefore, a mesh convergence was performed for both of the 
subdomains (tumor area and tissue area) independently in order to obtain optimal results. 
  From the mesh convergence, it was determined that a free mesh with a total of 2928 
elements would suffice.  The tumor subdomain has a total of 589 elements and a maximum 
element size 0.05 and the normal tissue subdomain has a total of 2339 elements with a maximum 
element size of 0.1.  These optimizations were determined based on when the average 
temperature reached a temperature that was stable with increasing elements in the mesh. (Figure 
3, Appendix B, Table 1B). 
 
 
Figure 3: Mesh convergence data shown graphically.  This representation makes it clear that the 
values chosen for tissue and tumor mesh are within the region of convergence but are also small 
enough that there is not excessive computation time. 
 
Modeling Steps 
 
  In order to accurately model the alternate treatment proposed, we had to first model the 
freezing of the tumor with a probe cooled by liquid nitrogen and then apply those conditions as 
initial conditions to the RF heating treatment of the probe.  This was done by first establishing a 
123K temperature boundary at the probe boundary and running the heat transfer model for ten 
minutes of freezing.  This solution was stored in the COMSOL solver manager and then could be 
applied as the initial condition once we changed the boundary to a constant voltage and asked the 
program to solve for both temperature and voltage for the thirty minute RF heating stage. 
  Creating an accurate model was accomplished in three steps.  The first was to establish 
the voltage used during the RF heating stage.  Sun et al. (2008) reported that a treatment of just 
heating the tumor (without pre-freezing) killed the cells of the tumor in a radius of 8.5mm.  
Therefore, the voltage was experimentally varied in order to yield this radius of cell death 
according to the output of the equation cell_survival_heating.  The next step was to apply the       Group 11  6/24 
same voltage to the model for alternate treatment and vary the energy of inactivation to yield a 
radius of tumor cell death of 9.5mm (1).  The final step was to use the determined inactivation 
energy and again vary the voltage of the RF heating stage in order to kill the radius of the tumor 
cell modeled in COMSOL. 
 
Freezing Model 
 
  The first model established in COMSOL is that of the freezing stage.  The surface plot is 
for the final temperature after ten minutes of contact with the probe and temperature graphs 
given are for the entire process (Appendix C Figures 2C, 3C). 
 
Heating Model: Voltage Determination 
 
  Using the COMSOL model for heating only, we determined that the optimal voltage for 
the RF heating stage was 17.6V as that yielded a radius of cell death that agrees with the results 
of Sun et al. (2008) (Appendix C Table 2C).  The surface plot is for the final temperature after 
thirty minutes of contact with the probe and temperature graphs given are for the entire process 
(Figure 4, Appendix C Figures 4C, 5C). 
 
 
Figure 4: The surface plot after heating for thirty minutes of the equation given by Sun et al. 
(2008) for the cellular survival rate defined as cell_survival_heating within the COMSOL 
program.  The blue areas indicate areas of cell death and the red indicates cell survival. 
  
Alternative Treatment: Inactivation Energy Determination 
 
  The energy of inactivation was determined using the model for the alternate treatment 
(freezing the tumor for ten minutes and then RF heating for thirty minutes).  By fitting the radius       Group 11  7/24 
of cell death to the results of the paper (9.5mm), the energy of inactivation was determined to be 
143,200cal/mol (Appendix C Table 3C).  The surface surface plots show the final temperature 
and cell survival after the full forty minutes and the temperature graphs given are for the RF 
heating process following the ten minute freezing (Figure 5, Appendix C Figures 6C, 7C). 
 
 
Figure 5: The surface plot after the alternate treatment using the equation for cellular survival 
rate.  This was fit to the results given by Sun- the radius of cell death is 9.5mm. 
 
Alternative Treatment: Adjustment to Optimize Tumor Death 
 
  The voltage required to destroy the entire tumor modeled was determined using the 
energy of inactivation (143,200cal/mol) and varying the voltage to fit the radius of the physical 
tumor.  This voltage was determined to be 20V (Appendix C, Table 4C).  The surface plots show 
the final temperature and cell survival after the full forty minutes of treatment and the 
termperature graphs given are for the RF heating process following the ten minutes of pre-
freezing (Figure 6, Appendix C Figures 8C, 9C). 
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Figure 6: The surface plot after the alternate treatment with RF heating voltage = 20V using the 
equation for cellular survival rate.  It is clear that the entire tumor area was destroyed and 
minimal normal tissue was compromised. 
 
Sensitivity Analysis 
 
We tested the sensitivity of our model by varying tissue density and thermal conductivity, 
tumor density and thermal conductivity, and heat capacity. We did this by altering values by 
±20%, and observing the difference in results (Figure 7). 
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Figure 7: Sensitivity analysis of thermal parameters.  The 0% figure is the input parameter for 
the corresponding property (Appendix A, Table 1A).  It is clear that even a 20% variance of 
these parameters leads to minimal changes to the outcome of the COMSOL model. 
 
We also performed a sensitivity analysis of the energy of inactivation, but used smaller 
percent differences (±5%, ±2.5%, ±1%) given that it is such a large value even these small 
changes can have a significant impact on the results (Figure 8, Appendix C Table 5C). 
 
 
Figure 8: Sensitivity analysis of the energy of inactivation is shown graphically.  The value for a 
percent difference of -5% is excluded as the COMSOL model predicted the destruction of the 
entire tissue. 
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Validation 
 
  First, it was verified that 17.6 V and 20.0 V are resonable voltage values for RF ablation.  
Nikolic et al. (2009) report that RF probes for tissue ablation typically have a current of 140 +/- 
35 mA, and a power of 2-5 W (7).  Using Ohm’s Law (Power=IV) for the typical current range, 
17.6 V yields a power between 1.85 W and 3.08 W, and 20 V yields a power between 2.10 W 
and 3.50 W (Appendix B Table 2B, Equation 3B).  Therefore the voltage of 20 V is reasonable 
for the entire range of possible currents, while the voltage of 17.6 V is reasonable as long as the 
current is set above 115 mA. 
The model we developed using the COMSOL software was validated primarily by 
comparing the energy of inactivation we found experimentally (143200cal/mol) to the energy of 
inactivation provided by the paper (143,898cal/mol).  The calculated percent error was 0.485%, 
which is well within acceptable range for percent error.  The calculation is shown below 
(Equation 1). 
(1) 
 
Conclusion and Design Recommendations 
Conclusions 
 
The tumor ablation model implemented in COMSOL demonstrated that freeze-thaw 
cycling increased the radius of tumor death by 9.6% compared to RF heating.   Furthermore, we 
found that the increased effectiveness of freeze-thaw cycling is relatively independent from the 
material properties of the tumor or the surrounding normal tissue such as the specific heat, 
density, and thermal conductivity, but is highly dependent on the inactivation energy of the 
tissue. 
In our model, freeze-thaw cycling increased the radius of tumor death from 8.684 mm to 
9.514 mm, compared with simple RF heating at 17.6 V.  The model was verified by 
implementing the RF heating and freeze-thaw cycle treatment implemented by Sun (2008), and 
comparing the tumor death diameter to the literature reported value.  We determined that the 
inactivation energy required to destroy a 12.7 mm tumor radius was 143200cal/mol, a 0.0485% 
difference from the inactivation energy value of 143,898 cal/mol proposed by Sun et al.   
The use of a computer model is crucial to demonstrating the effect of pre-freezing on 
tumor death radius. If an experiment was conducted in vivo, each replicate of an experiment 
would require a new tumor.  Therefore, if an in vivo experiment were used, it would be very 
difficult to confirm that the increased cell death is due to the freeze-thaw cycling and not 
variation between individual tumors.   
Our group determined that the voltage of the probe should be increased to 20 V to 
successfully destroy the tumor as defined in the model with a radius of 12.5 mm.  The sensitivity 
analysis shows that varying the material properties by 20% resulted in cell death radius to vary 
by less than 0.5 mm.  More strikingly, the COMSOL model uses specific heat, density, and 
thermal conductivities from sources outside of Sun et al, but the results are very similar 
regardless of the differing material properties.  
       Group 11  11/24 
 
Design Recommendations 
 
The COMSOL model could be used to examine the effects of many procedural variations 
in tumor treatment.  Many different freeze-thaw procedures can be implemented by changing the 
heating and cooling time, probe diameter, number of freeze-thaw cycles, and number of probes 
in the model.  While it was confirmed that freeze-thaw cycling is more effective than RF heating, 
the model must be tested for all biologically relevant parameter ranges before it is tested on 
animals or humans.  To examine the feasibility of freeze-thaw treatment in human cases, a 
Monte Carlo analysis could be conducted to test many different tumor parameters.  MRI images 
of real tumor geometries could also be used to determine the effects of freeze-thaw cycling using 
more realistic tumor geometry.   While our model demonstrates that freeze-thaw cycling can be 
beneficial in tumor treatment, future research must determine which geometries and tumor types 
would benefit from the freeze-thaw cycling tumor treatment.  
Modeling in COMSOL is both faster and more humane than using animal models for 
testing purposes, avoiding the ethical concerns of animal research.  Through the model, one 
could iteratively optimize all aspects of the problem and then test a finalized procedure 
experimentally. The model also provides a direct comparison of freeze-thaw and RF heating 
treatment procedures on the same tumor, which would not possible to achieve through animal 
testing.  
Given that lung tumors vary greatly in size and geometry, the data from the COMSOL 
model could be used by doctors to set an appropriate voltage for a freeze-thaw cryosurgery 
procedure.  The geometry could be scaled to different sizes to create a chart indicating the 
appropriate applied voltage for a given tumor size.  The relationship between tumor size and 
appropriate probe voltage would be crucial in minimizing damage to healthy tissue, and must be 
determined before the probe could be used in human trials. 
The freeze-thaw procedure combines both cryosurgical and RF ablation, two commonly 
used surgical techniques.   By incorporating two approaches that are already in human use, 
clinical trials for freeze-thaw cycling would be safer than testing a completely new approach, 
such as experimental medications.   Additionally, the freeze-thaw probe combines a common RF 
probe, with a liquid nitrogen cooled tip, a small variation on an existing device that could be 
easily manufactured.  Combining two common approaches would be fairly inexpensive to 
develop and produce, may result in faster approval from the FDA than a completely new 
approach, and provide more effective lung tumor treatment with comparable patient risk to 
current treatment procedures. 
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Appendix A: Mathematical statement of the problem 
 
Governing Equations 
 
Freezing 
 
2
2 1
z
T
r
T r
r r
k
t
T cpa             (1A) 
 
 
Table 2A: Values for the apparent specific heat  
 
Temperature, 
T [K] 
Apparent 
specific heat, 
cpa [J/KgK] 
18  4180 
248  4180 
261  5000 
265  10000 
268  20000 
269  80000 
270  44000 
270.5  20000 
271  4180 
333  4180 
 
 
 
Heating 
Q
z
T
r
T r
r r
k
t
T cpa 2
2 1
  (2A) 
 
  , where E is defined by the voltage equation 
 
                     (3A) 
   
 
              (4A)
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Input Parameters 
 
Table 1A: Parameters used for the model in COMSOL. 
 
Parameter Name  Units  Value  Source  Notes 
Thermal 
Conductivity of 
Healthy Tissue (k)   W/mK  0.245  4, 5 
Original values taken from (5). 
Values for frozen and unfrozen 
materials averaged in (4) 
Thermal 
Conductivity of 
Tumor (k)  W/mK  1.401  4,5  "  '' 
Density of 
Healthy Tissue (p)  kg/m
3  960  4, 5 
Original values taken from (5). 
Values for frozen and unfrozen 
materials averaged in (4) 
Density of Tumor 
(p)  kg/m
3  200  4,5  '' '' 
Specific Heat of 
both Tumor and 
Tissue (Cp)  J*(kg K)
-1   Tabulated   3 
Tablulated Values refer to the 
specific heat of water (refer to 
chart in project text) 
Intitial 
Temperature 
(T_int)  K  310  4  Body temperature 
Probe 
Temperature  K  123  4   
Water Content  kg/kg  0.8  4    
Latent Heat  kJ/kg  333  4 
Assumed to be latent heat of 
water based on high water 
content 
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Appendix B: Solution Strategy 
 
Cell Death Equation 
 
Sheat = 1 – [F(t)]
n = 1 – (1 – e
-kst)
n            (1B) 
 
          (2B) 
 
Mesh Convergence 
 
TUMOR      NORMAL TISSUE 
No. Elements  Sub Int 
Average 
Temp.     No. Elements  Sub Int  Average Temp. 
44  0.051018  335.527523     65  0.479512  312.1822917 
84  0.050983  335.2973402     226  0.479444  312.1380208 
246  0.050975  335.244727     551  0.479438  312.1341146 
314  0.050978  335.264457     775  0.479451  312.1425781 
589  0.050975  335.244727     2339  0.479452  312.1432292 
785  0.050976  335.2513037     6621  0.479456  312.1458333 
2626  0.050976  335.2513037     26549  0.479463  312.1503906 
Table 1B: Mesh convergence analysis for both the tumor and normal tissue subdomains in the 
model.  For the tumor, the mesh with 589 subunits was chosen and for the normal tissue, the 
mesh with 2339 subunits was chosen. 
 
RF Voltage Validation 
 
P=VI                      (3B) 
 
Voltage = 20V 
Current (mA)  Power (W) 
Low = 105mA  2.10 
Average = 140mA  2.80 
High = 175mA  3.50 
Voltage = 17.6V 
Current (mA)  Power (W) 
Low = 105mA  1.85 
Average = 140mA  2.46 
High = 175mA  3.08 
Table 2B: Shows the calculation for the power of both of the voltages applied to the RF probe 
using different current values.  The normal range of power is 2-5W, thus it is clear that all of the 
values are within that range except using a low current for the applied voltage of 17.6V.  This 
can easily be avoided by using a higher current for the treatment. 
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Figure 1B: Mesh plot with 589 subunits for the normal tissue and 2339 subunits for the tumor.      Group 11  16/24 
Appendix C: Additional Visuals 
 
  For each of the different models reported, both surface plots and point plots over time are 
given to express relevant data.  For the point plots, three are given (points A, B, and C) for each 
model run in COMSOL.  These points are consistent throughout the report to allow direct 
comparison.  All of the points are within the tumor: A is close to the probe, B is in the center of 
the tumor, and C is near the tumor-normal tissue interface (Table 2, Figure 3). 
 
Location (all 
within tumor) 
r  z 
(A) near 
probe 
0.002128  0.039082 
(B) center  0.007877  0.034992 
(C) boundary  0.011019  0.031673 
Table 1C: The coordinates of the points plotted in each of the COMSOL simulations. 
Figure 1C: The physical location of each of the points (A, B, and C) plotted for the different 
COMSOL simulations. 
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Freezing Model 
 
Figure 2C: The temperature surface plot after freezing shows that the tumor tissue immediately 
surrounding the probe has reached a temperature of -150°C (123K) after ten minutes of contact 
with the probe.  The data from this simulation was saved in COMSOL and then used as the 
initial condition for the RF heating phase. 
 
 
Figure 3C: Temperature profiles after freezing for points A, B, and C defined previously.  As 
expected, the steepest temperature drop is observed closest to the probe in the tumor within the 
first minute of cooling.  The other two points demonstrate a more gradual cooling over the 
duration of probe contact.       Group 11  18/24 
Heating Model: Voltage Determination 
 
Voltage 
(V) 
Radius of 
Cell Death 
(mm) 
15  3.837 
17  6.826 
17.5  8.194 
17.6  8.684 
17.7  8.996 
18  9.824 
19  11.587 
20  12.316 
Table 2C: Demonstrates the experimental variation of the voltage of the RF heating probe and 
the resulting tumor cell death.  The optimal voltage was determined to be 17.6V (highlighted). 
 
 
Figure 4C:  The temperature surface plot after heating for thirty minutes shows that the tumor 
tissue immediately surrounding the probe has reached a high temperature of 69.2°C (342.2K) 
and that the majority of the normal tissue remains at body temperature. 
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Figure 5C: Temperature and cell survival rate plots for points A, B, and C.  For the cell survival 
plot, it is clear that the equation calculated is designed to either solve for living or death as the 
interval over which a cell dies is approximately 150s. 
 
Alternative Treatment: Inactivation Energy Determination 
 
Energy of 
Inactivation 
(cal/mol) 
Radius of 
Cell Death 
(mm) 
140000  17.686 
141000  14.655 
142000  12.519 
143000  10.676 
143100  9.954 
143200  9.514 
143300  8.909 
143500  8.096 
143700  7.366 
143898  6.772 
144000  6.468 
145000  4.521 
150000  1.7 
Table 3C: Demonstrates the experimental variation of the energy of inactivation (ΔH) caused by 
the pre-freezing and the resulting tumor cell death.  The optimal ΔH was determined to be 
143,200cal/mol (highlighted). 
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Figure 6C: The temperature surface plot after alternate treatment.  This result is very similar to 
the heating only surface plot, but the maximum temperature is 65.2°C (338.2K), which is less 
than the maximum temperature of the heating model because the initial temperature was 
significantly lower due to the ten minute pre-freezing. 
 
 
Figure 7C: Temperature and cell survival rate plots for points A, B, and C for the RF heating 
stage of the alternate treatment.  From the initial temperatures of each of the points, it is clear 
that the initial conditions for the heating stage were yielded from the end result of ten minutes of 
freezing. 
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Alternative Treatment: Adjustment to Optimize Tumor Death 
 
 
Voltage 
(V) 
Radius of Cell 
Death (mm) 
17.6  9.514 
18  10.981 
19  11.806 
20  12.698 
21  13.504 
22  14.334 
Table 4C: Demonstrates the experimental variation of the voltage and the resulting tumor cell 
death.  The optimal voltage for the COMSOL model was determined to be 20V (highlighted). 
 
 
Figure 8C: The temperature surface plot after alternate treatment fit to the COMSOL model.  The 
result is very similar to the alternate treatment modeled with RF heating voltage = 17.6V except 
the maximum temperature is higher given the higher voltage of RF heating. 
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Figure 9C: Temperature and cell survival rate plots for points A, B, and C for the RF heating 
stage of the alternate treatment.  It is clear that all of the points demonstrate tumor cell death at 
the end of the forty minute treatment. 
 
Sensitivity Analysis 
 
Percent 
Difference 
Energy of 
Inactivation 
[cal/mol] 
Radius of 
Cell Death 
[mm] 
-5  136040  Error 
-4.5  136756  Error 
-4  137472  Error 
-3.5  138188  Error 
-3  138904  Error 
-2.7  139262  Error 
-2.5  139620  22.111 
-1  141768  15.189 
0  143200  12.698 
1  144632  10.611 
2.5  146780  5.038 
5  150360  2.136 
Table 5C: Sensitivity analysis of the energy of inactivation was determined and is shown here in 
table form.  The “error” entries indicate values of ΔH for which the program predicted that all of 
the tissue (tumor and normal) would be killed by the procedure. 
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